Shyr‐Te Ju

3.8k total citations
75 papers, 3.2k citations indexed

About

Shyr‐Te Ju is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shyr‐Te Ju has authored 75 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Immunology, 32 papers in Molecular Biology and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shyr‐Te Ju's work include T-cell and B-cell Immunology (30 papers), Immune Cell Function and Interaction (25 papers) and Monoclonal and Polyclonal Antibodies Research (18 papers). Shyr‐Te Ju is often cited by papers focused on T-cell and B-cell Immunology (30 papers), Immune Cell Function and Interaction (25 papers) and Monoclonal and Polyclonal Antibodies Research (18 papers). Shyr‐Te Ju collaborates with scholars based in United States, Japan and Taiwan. Shyr‐Te Ju's co-authors include Shu Man Fu, Ann Marshak‐Rothstein, Rahul Sharma, Sun‐Sang J. Sung, Alfred Nisonoff, Felicia Gaskin, Ken Matsui, Charles E. Rose, Steven R. Beaty and Martin E. Dorf and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Shyr‐Te Ju

75 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shyr‐Te Ju United States	28	2.0k	1.2k	459	323	315	75	3.2k
Alvin E. Davis United States	42	1.8k 0.9×	942 0.8×	226 0.5×	347 1.1×	202 0.6×	105	4.9k
H. Michael Shepard United States	5	991 0.5×	1.1k 0.9×	229 0.5×	510 1.6×	425 1.3×	5	2.6k
Kendall M. Mohler United States	15	1.4k 0.7×	667 0.6×	300 0.7×	555 1.7×	399 1.3×	17	3.2k
T D Geppert United States	24	1.7k 0.9×	1.3k 1.1×	276 0.6×	680 2.1×	450 1.4×	35	3.2k
Jane Tian United States	28	2.3k 1.2×	1.1k 0.9×	160 0.3×	659 2.0×	375 1.2×	37	3.8k
Hironobu Asao Japan	35	2.6k 1.3×	1.4k 1.2×	261 0.6×	1.2k 3.8×	338 1.1×	85	4.5k
Byungsuk Kwon South Korea	30	2.0k 1.0×	718 0.6×	118 0.3×	573 1.8×	246 0.8×	86	3.0k
K Nishioka Japan	30	888 0.4×	630 0.5×	196 0.4×	305 0.9×	217 0.7×	100	2.5k
P E Lipsky United States	31	2.2k 1.1×	841 0.7×	551 1.2×	455 1.4×	237 0.8×	46	3.6k
Druie Cavender United States	30	1.2k 0.6×	744 0.6×	332 0.7×	298 0.9×	201 0.6×	69	3.3k

Countries citing papers authored by Shyr‐Te Ju

Since Specialization

Citations

This map shows the geographic impact of Shyr‐Te Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shyr‐Te Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shyr‐Te Ju more than expected).

Fields of papers citing papers by Shyr‐Te Ju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shyr‐Te Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shyr‐Te Ju. The network helps show where Shyr‐Te Ju may publish in the future.

Co-authorship network of co-authors of Shyr‐Te Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Shyr‐Te Ju. A scholar is included among the top collaborators of Shyr‐Te Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shyr‐Te Ju. Shyr‐Te Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Chan, Derek V., et al.. (2013). A recombinant scFv-FasLext as a targeting cytotoxic agent against human Jurkat-Ras cancer. Journal of Biomedical Science. 20(1). 16–16. 10 indexed citations

2.

Ju, Shyr‐Te, et al.. (2012). IL-2 controls trafficking receptor gene expression and Th2 response for skin and lung inflammation. Clinical Immunology. 145(1). 82–88. 18 indexed citations

3.

Sharma, Rahul, Umesh S. Deshmukh, Lingjie Zheng, Shu Man Fu, & Shyr‐Te Ju. (2009). X-linked Foxp3 (Scurfy) Mutation Dominantly Inhibits Submandibular Gland Development and Inflammation Respectively through Adaptive and Innate Immune Mechanisms. The Journal of Immunology. 183(5). 3212–3218. 19 indexed citations

4.

Sharma, Rahul, et al.. (2009). IL-2 Regulates CD103 Expression on CD4+ T Cells in Scurfy Mice that Display Both CD103-Dependent and Independent Inflammation. The Journal of Immunology. 183(2). 1065–1073. 21 indexed citations

5.

Sharma, Rahul, Lingjie Zheng, Umesh S. Deshmukh, et al.. (2007). Cutting Edge: A Regulatory T Cell-Dependent Novel Function of CD25 (IL-2Rα) Controlling Memory CD8+ T Cell Homeostasis. The Journal of Immunology. 178(3). 1251–1255. 33 indexed citations

6.

Zheng, Lingjie, Rahul Sharma, Felicia Gaskin, Shu Man Fu, & Shyr‐Te Ju. (2007). A Novel Role of IL-2 in Organ-Specific Autoimmune Inflammation beyond Regulatory T Cell Checkpoint: Both IL-2 Knockout and Fas Mutation Prolong Lifespan of Scurfy Mice but by Different Mechanisms. The Journal of Immunology. 179(12). 8035–8041. 34 indexed citations

7.

Sung, Sun‐Sang J., Shu Man Fu, Charles E. Rose, et al.. (2006). A Major Lung CD103 (αE)-β7 Integrin-Positive Epithelial Dendritic Cell Population Expressing Langerin and Tight Junction Proteins. The Journal of Immunology. 176(4). 2161–2172. 397 indexed citations

8.

Jodo, Satoshi, Vyankatesh Pidiyar, Sheng Xiao, et al.. (2005). Cutting Edge: Fas Ligand (CD178) Cytoplasmic Tail Is a Positive Regulator of Fas Ligand-Mediated Cytotoxicity. The Journal of Immunology. 174(8). 4470–4474. 12 indexed citations

9.

Sharma, Rahul, Harini Bagavant, Wael N. Jarjour, Sun‐Sang J. Sung, & Shyr‐Te Ju. (2005). The Role of Fas in the Immune System Biology of IL-2Rα Knockout Mice: Interplay among Regulatory T Cells, Inflammation, Hemopoiesis, and Apoptosis. The Journal of Immunology. 175(3). 1965–1973. 26 indexed citations

10.

Xiao, Sheng, Umesh S. Deshmukh, Satoshi Jodo, et al.. (2004). Novel Negative Regulator of Expression in Fas Ligand (CD178) Cytoplasmic Tail: Evidence for Translational Regulation and against Fas Ligand Retention in Secretory Lysosomes. The Journal of Immunology. 173(8). 5095–5102. 9 indexed citations

11.

Jodo, Satoshi, Sheng Xiao, Andreas M. Hohlbaum, et al.. (2001). Apoptosis-inducing Membrane Vesicles. Journal of Biological Chemistry. 276(43). 39938–39944. 52 indexed citations

12.

Hohlbaum, Andreas M., Meredith S. Gregory, Shyr‐Te Ju, & Ann Marshak‐Rothstein. (2001). Fas Ligand Engagement of Resident Peritoneal Macrophages In Vivo Induces Apoptosis and the Production of Neutrophil Chemotactic Factors. The Journal of Immunology. 167(11). 6217–6224. 134 indexed citations

13.

Matsui, Ken, Sheng Xiao, Alan Fine, & Shyr‐Te Ju. (2000). Role of Activator Protein-1 in TCR-Mediated Regulation of the Murine fasl Promoter. The Journal of Immunology. 164(6). 3002–3008. 26 indexed citations

14.

Jodo, Satoshi, Andreas M. Hohlbaum, Sheng Xiao, et al.. (2000). CD95 (Fas) Ligand-Expressing Vesicles Display Antibody-Mediated, FcR-Dependent Enhancement of Cytotoxicity. The Journal of Immunology. 165(10). 5487–5494. 33 indexed citations

15.

Jodo, Satoshi, David Strehlow, & Shyr‐Te Ju. (2000). Bioactivities of Fas Ligand-Expressing Retroviral Particles. The Journal of Immunology. 164(10). 5062–5069. 14 indexed citations

16.

Ju, Shyr‐Te, Ken Matsui, & Metin Özdemirli. (1999). Molecular and Cellular Mechanisms RegulatingTand B Cell Apoptosis through Fas/FasL Interaction. International Reviews of Immunology. 18(5-6). 485–513. 50 indexed citations

17.

Xiao, Sheng, Ken Matsui, Alan Fine, et al.. (1999). FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3. European Journal of Immunology. 29(11). 3456–3465. 50 indexed citations

18.

Xiao, Sheng, Ken Matsui, Alan Fine, et al.. (1999). FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3. European Journal of Immunology. 29(11). 3456–3465. 4 indexed citations

19.

Ju, Shyr‐Te, Michel Pierres, Ronald N. Germain, Baruj Benacerraf, & Martin E. Dorf. (1979). Idiotypic analysis of anti-GAT antibodies. VI. Identification and strain distribution of the GA-1 idiotype.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 123(6). 2505–10. 14 indexed citations

20.

Ju, Shyr‐Te, Thomas J. Kipps, Jacques Thèze, Baruj Benacerraf, & Martin E. Dorf. (1978). Idiotypic analysis of anti-GAT antibodies. I. Presence of common idiotypic specificities in both responder and nonresponder mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 121(3). 1034–9. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact